National Cancer Center to Collaborate on Cancer Research with US National Cancer Institute

The National Cancer Center announced on the 28th that it signed a memorandum of understanding (MOU) for comprehensive cancer research cooperation between the two countries on the 26th (local time) at the U.S. National Cancer Institute located in Bethesda, Maryland, USA.

On the 26th (local time), a memorandum of understanding was signed between the National Cancer Center and the U.S. National Cancer Institute at the U.S. National Cancer Institute located in Bethesda, Maryland.
[Photo by National Cancer Center]

This agreement was made to coincide with President Yoon Suk-yeol's state visit to the U.S., based on the agreement to accelerate cooperation in cancer research and advanced cancer treatment between the two countries through the joint declaration of the two heads of state during U.S. President Joe Biden's visit to Korea in May last year.

The National Cancer Center and the U.S. National Cancer Institute have maintained mutual exchange and cooperation, having signed an MOU in 2011 for comprehensive research cooperation in the field of cancer genomics and another MOU in 2019 for cooperation in the field of cancer proteomics following the promotion of precision medicine.

With this agreement, the two countries plan to expand and strengthen their research cooperation, which was previously focused on cancer proteomics, to encompass the entire cancer continuum including cancer prevention, early diagnosis, treatment, and cancer survivor management. In particular, they plan to promote joint research in advanced bio-technologies such as cell therapy technology development, as well as personnel exchanges between the two institutions, hosting joint academic conferences, and forming a joint steering committee.

Seo Hong-gwan, Director of the National Cancer Center, said, “With this agreement, we have laid the foundation for comprehensive research cooperation to strengthen capabilities across the entire cancer continuum, from cancer prevention to cancer survivor management, beyond cancer proteomics research.” He added, “Through close cooperation between Korea and the U.S., we will seek ways to improve the quality of life for cancer patients and lead cancer research and development in advanced cancer diagnosis and treatment methods.”

This content was produced with the assistance of AI translation services.